Cargando…
Cytosolic delivery of the immunological adjuvant Poly I:C and cytotoxic drug crystals via a carrier-free strategy significantly amplifies immune response
Co-delivery of chemotherapeutics and immunostimulant or chemoimmunotherapy is an emerging strategy in cancer therapy. The precise control of the targeting and release of agents is critical in this methodology. This article proposes the asynchronous release of the chemotherapeutic agents and immunost...
Autores principales: | Du, Xiaoqing, Hou, Yuqi, Huang, Jia, Pang, Yan, Ruan, Chenlu, Wu, Wei, Xu, Chenjie, Zhang, Hongwei, Yin, Lifang, He, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546930/ https://www.ncbi.nlm.nih.gov/pubmed/34729315 http://dx.doi.org/10.1016/j.apsb.2021.03.014 |
Ejemplares similares
-
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T Cells
por: Di, Shengmeng, et al.
Publicado: (2019) -
Immune System Modulation by the Adjuvants Poly (I:C) and Montanide ISA 720
por: Marques, Rodolfo F., et al.
Publicado: (2022) -
A systematic review on poly(I:C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy
por: De Waele, Jorrit, et al.
Publicado: (2021) -
PUMA amplifies necroptosis signaling by activating cytosolic DNA sensors
por: Chen, Dongshi, et al.
Publicado: (2018) -
Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC
por: Lion, Eva, et al.
Publicado: (2011)